The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Click to play podcast
Maybe the only mistake Boston Scientific (NYSE:BSX) made when they hired Michael Mahoney as CEO was waiting so long to do it.
After spending much of the last half of a decade in a turnaround that never seemed to get off the ground, the medical device goliath seems to be on the up and up.
There’s a vast trove of potentially valuable data salted throughout the U.S. healthcare system, but as yet nobody’s figured out how to connect the data silos to leverage the power of "Big Data" in a significant way.
Healthcare providers are looking to medical devices to play a new role in hospital care, providing a whole-patient view of health through technologies that talk to each other and help clinicians make decisions about treatment.
Veniti founder, president & CEO Sean Morris is on the march, looking to take over venous disease treatment with a suit of specialized devices that he hopes will knock out their more generic forebears.
Veniti, formed in 2009, specializes in devices for the venous anatomy, an arena often covered in a larger medical device company’s vascular devices business.
Click to play
Philipp Lang has ConforMIS looking to get a leg up on the knee replacement industry.
Last week, the Burlington, Mass.-based orthopedic implant maker said it raised $89 million in a Series E round from several investors, bringing the total nut raised by ConforMIS over the last 3 years to more than $140 million – a somewhat remarkable amount, given the fundraising climate over the past few years.
Click to play
Soteira CEO Larry Jasinski is no stranger to adversity.
Click to play
David Hankin became CEO at health research institute The Alfred Mann Foundation in a rather roundabout way.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this Halloween, make sure you’re still in the know with MassDevice +3.
Click to play
When Stuart Long accepted the keys to the corner office at Capsule Tech. North America earlier this month, he walked into a period of skyrocketing growth for the medical device connectivity company.
Venipuncture – drawing blood or establishing an intravenous feed – is the most common invasive medical procedure. For many patients, it’s a painful exercise in frustration when clinicians struggle to find a blood vessel, sometimes requiring multiple needle sticks.
AccuVein and CEO Ron Goldman aim to change all that with the company’s AV300 vascular illumination device. The wireless, handheld module uses a pair of lasers to paint a patient’s arm with light, making otherwise invisible or hard-to-find blood vessels apparent to the naked eye.
